Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$232.23 -0.12 (-0.05%)
As of: Sep 30, 2026 · 3:25 PM EDT

Jazz Pharmaceuticals (JAZZ) Retained Earnings (2010 - 2026)

Updated

Jazz Pharmaceuticals (JAZZ) recorded Retained Earnings of $1.13 billion in Q2 2026, up 491.7% from $191.31 million a year earlier and up 20.5% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Retained Earnings (2010 - 2026) Analysis & Trends

At the end of FY2025, Jazz Pharmaceuticals reported Retained Earnings of $646.1 million, down 42.7% from FY2024.

  • Annual Retained Earnings has a five-year compound annual growth rate of -11.0% (FY2020 to FY2025).
  • Across earlier years, Retained Earnings came in at $1.13 billion in FY2024 (+28.3%), $878.66 million in FY2023 (+19.8%), $733.59 million in FY2022 (-11.6%) and $830.23 million in FY2021 (-28.4%).
  • The Q2 2026 figure is the highest quarterly Retained Earnings since Q1 2021.
  • On a year-over-year basis, Retained Earnings rose in four of the last eight quarters, with growth averaging 45.4%.
  • Peak year-over-year performance for Retained Earnings in the last five years was growth of 491.7% in Q2 2026, against a decline of 78.0% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $939.2 million (Q1 2026), $646.1 million (Q4 2025) and $442.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 171.67 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -17.33 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 12.59 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 2.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 15.69 Bn
10 Jazz Pharmaceuticals 15.08 Bn 8.90 Bn 1.09 Bn 1.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.13 Bn
Mar 31, 2026 939.20 Mn
Dec 31, 2025 646.10 Mn
Sep 30, 2025 442.73 Mn
Jun 30, 2025 191.31 Mn
Mar 31, 2025 1.03 Bn
Dec 31, 2024 1.13 Bn
Sep 30, 2024 936.23 Mn
Jun 30, 2024 871.18 Mn
Mar 31, 2024 864.04 Mn
Dec 31, 2023 878.66 Mn
Sep 30, 2023 884.30 Mn
Jun 30, 2023 811.85 Mn
Mar 31, 2023 803.01 Mn
Dec 31, 2022 733.59 Mn
Sep 30, 2022 974.31 Mn
Jun 30, 2022 993.96 Mn
Mar 31, 2022 959.35 Mn
Dec 31, 2021 830.23 Mn
Sep 30, 2021 865.58 Mn
API Access

Jazz Pharmaceuticals Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=JAZZ&period=max&api_key=YOUR_API_KEY